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1997); and cleavage of nuclear lamins by caspase-3
and caspase-6 may contribute to nuclear membrane
breakage (Lazebnik et al., 1995).
Caspases that function in the apoptotic pathway exist
as inactive zymogens in the cytosol of living cells and
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become activated through proteolysis when cells re-Center at Dallas
ceive apoptotic signals. These signals include activationDallas, Texas 75235
of cell surface death receptors such as Fas and TNF,
growth factor deprivation, DNA damage, and treatment
with a variety of chemotherapeutic drugs (reviewed bySummary
Salvesen and Dixit, 1997; Cryns and Yuan, 1998). Cas-
pase activation during apoptosis is presumed to occurWe report here the purification of a cytosolic protein
through a caspase cascade that is most likely initiatedthat induces cytochrome c release from mitochondria
by caspases containing long NH2-terminal domains thatin response to caspase-8, the apical caspase activated
mediate interaction with other caspase-activating fac-by cell surface death receptors such as Fas and TNF.
tors. For example, during Fas activation, caspase-8 isPeptide mass fingerprinting identified this protein as
recruited to the death induced signaling complex (DISC)Bid, a BH3 domain±containing protein known to inter-
on the cell surface through interaction with FADD/MORT-1act with both Bcl2 and Bax. Caspase-8 cleaves Bid,
(Boldin et al., 1996; Muzio et al., 1996). Caspase-9, onand the COOH-terminal part translocates to mitochon-
the other hand, forms a complex with Apaf1 and cyto-dria where it triggers cytochrome c release. Immuno-
chrome c in the presence of dATP/ATP (Li et al., 1997).depletion of Bid from cell extracts eliminated the
Caspase-8 and caspase-9 presumably become acti-cytochrome c releasing activity. The cytochrome c
vated through autocatalysis within these multiproteinreleasing activity of Bid was antagonized by Bcl2. A
complexes (Cryns and Yuan, 1998). The activated cas-mutation at the BH3 domain diminished its cyto-
pase-8 or caspase-9 in turn cleaves and activates otherchrome c releasing activity. Bid, therefore, relays an
caspases such as caspase-3, caspase-6, and cas-apoptotic signal from the cell surface to mitochondria.
pase-7, which lack the long NH2-terminal domain but
constitute the main caspase activity in apoptotic cells
Introduction
(Srinivasula et al., 1996; Faleiro et al., 1997; Li et al.,
1997; Muzio et al., 1997).
Apoptosis, a form of cell death characterized by cell Holocytochrome c, whichnormally resides exclusively
shrinkage, membrane blebbing, nuclear breakdown, in the intermembrane space of mitochondria, is released
and DNA fragmentation, is essential for development, into the cytosol during apoptosis (Liu et al., 1996b).
maintenance of tissue homeostasis, and elimination of Release of cytochrome c from mitochondria inactivates
harmful cells in metazoan organisms (reviewed by Ja- the electron transfer chain and triggers caspases activa-
cobson et al., 1997; Nagata, 1997). Malfunctions of apo- tion through Apaf1 (Krippner et al., 1996; Li et al., 1997).
ptosis have been implicated in many forms of human Cytochrome c release from mitochondria has been ob-
disease such as cancer, neurodegenerative disease, served in cells undergoing apoptosis induced by signals
AIDS, and ischemic stroke (reviewed by Thompson, including the activation of Fas and TNF, growth factor
1995). deprivation, excessive DNA damage, and treatment of
Caspases, a group of cysteine proteases that cleave chemotherapeutical drugs (reviewed by Reed, 1997).
protein substrates after aspartic acids, play a central Overexpression of Bcl2 or Bcl-xL blocks the release of
role in the regulation and execution of apoptosis (re- cytochrome c and aborts the apoptotic response (Kluck
viewed by Cryns and Yuan, 1998). Mutations in the C. et al., 1997; Yang et al., 1997). Overexpression of Bax,
elegans caspase CED-3 abolished apoptosis in this ani- a proapoptotic member of the Bcl2 family of proteins, or
mal (Yuan et al., 1993). Homologous deletion of cas- its Bcl2 homologous domain 3 (BH3 domain), promotes
pase-3 from the mouse genome resulted in an accumu- cytochrome c release (Cosulich et al., 1997; Jurgens-
lation of excess neurons in the mouse brain due to a meier et al., 1998; Rosse et al., 1998; Pastorino et al.,
lack of apoptosis (Kuida et al., 1996). Several important 1998).
morphological features of apoptosis are caused by cas- The mechanism of cytochrome c release in response
pase activity. For example, cleavage of DFF45/ICAD by to apoptotic stimuli and its regulation by the Bcl2 family
caspase-3 results in characteristic chromatin condensa- of proteins is unclear. Inasmuch as the structure of
tion and fragmentation during apoptosis (Liu et al., 1997; Bcl-xL is reminiscent of pore-forming proteins of bacte-
Enari et al., 1998; Liu et al., 1998); cleavage of fodrin, rial toxins such as diphtheria toxin and colicins, it has
gelsolin, and PAK2 by caspases causes morphological been hypothesized that Bcl-xL may function as an ion
changes in the cell membrane and cytoskeleton (Martin channel that regulates the permeability of mitochondria
et al., 1995; Kothakota et al., 1997; Rudel and Bokoch, (Muchmore et al., 1996; Minn et al., 1997; Vander Heiden
et al., 1997). Suchan ion channel could minimize osmotic
stress and indoing so prevent cytochrome c release due*To whom correspondence should be addressed.
²These authors contributed equally to this work. to mitochondrial matrix swelling and outer membrane
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disruption (Vander Heiden et al., 1997). Indeed, both
swelling of the mitochondrial matrix and bursting of the
outer membrane were observed in cells treated with
agonistic antibody against Fas (Vander Heiden et al.,
1997). However, whether such a phenomenon is the
cause of cytochrome c release or an effect of the apo-
ptotic program is unclear.
Activation of cell surface receptor Fas leads to rapid
inactivation of the electron transfer activity of cyto-
chrome c and subsequent release of cytochrome c from
mitochondria (Krippner et al., 1996; Vander Heiden et
al., 1997; Scaffidi et al., 1998; Srinivasan et al., 1998).
The inactivation and release of cytochrome c induced
by Fas activation is sensitive to z-VAD-fmk, a broad
range caspase inhibitor (Krippner et al., 1996; Vander
Heiden et al., 1997; Scaffidi et al., 1998). Since activation
Figure 1. Caspase-8-Induced Cytochrome c Release from Mito-of cell surface death receptor leads to rapid activation
chondria Requires a Cytosolic Factorof caspase-8, the apical caspase in the Fas-induced
Mouse liver mitochondria, HeLa S-100, and recombinant caspase-8apoptotic pathway, the loss of cytochrome c from mito-
were prepared as described in Experimental Procedures. Recombi-chondria is likely a result of caspase-8 activation. In-
nant CrmA was prepared as in Liu et al., 1996a. Aliquots of 3 ml of
deed, addition of active caspase-8 to a Xenopus cell- mouse liver mitochondria (z3 mg) were incubated either alone (lane
free system induces rapid cytochrome c release from 1), or in the presence of aliquots of 2 ml caspase-8 (20 ng) (lanes 2,
mitochondria (Kuwana et al., 1998). and 4±6), or 10 ml (50 mg) of HeLa S-100 extracts (lanes 3±6) in a
final volume of 25 ml buffer B. In lanes 5 and 6, an aliquot of 0.3 mgThe activation of caspase-8, therefore, initiates two
of CrmA (lane 5) or z-VAD-fmk at a final concentration of 20 mMpathways leading to the activation of downstream cas-
was preincubated with caspase-8 for 15 min prior to the additionpases. Caspase-8 can activate downstream caspases
of HeLa S-100 and mitochondria. After incubation at 308C for 1 hr,
like caspase-3, caspase-6, and caspase-7 by directly the samples were centrifuged at 12,000 3 g for 5 min at 48C to pellet
cleaving them (Srinivasula et al., 1996; Muzio et al., the mitochondria.
1997). In addition, caspase-8 activates these down- (A) The resulting supernatants were subjected to 15% SDS-PAGE
and transferred to a nitrocellulose filter. The filter was probed withstream caspases indirectly by causing cytochrome c
a monoclonal anti-cytochrome c antibody as described in Experi-release from mitochondria that triggers caspase activa-
mental Procedures. The filter was then exposed to X-ray film for 3 s.tion through Apaf1. The latter pathway is regulated by
(B) The resulting pellets were resuspended in 25 ml SDS sample
Bcl2 or Bcl-xL while a caspase-8 inhibitor like CrmA buffer, subjected to 15% SDS-PAGE, and transferred to a nitrocellu-
blocks both pathways (Strasser et al., 1995; Srinivasula lose filter. The filter was probed with a monoclonal anti-cytochrome
et al., 1996; Boise and Thompson, 1997; Vander Heiden c antibody and then exposed to X-ray film for 3 s.
(C) The same filter as in (B) was erased and reprobed with a mono-et al., 1997; Medema et al., 1998; Srinivasan et al., 1998).
clonal anti-cytochrome c-oxidase antibody (Molecular Probes) fol-The contributions of these two pathways to Fas-induced
lowed by ECL detection and exposure to X-ray film for 20 s.cell death vary between different cell types, presumably
due to different levels of activated caspase-8 and its
downstream substrates in a particular cell type (Scaffidi
(Boldin et al., 1996; Muzio et al., 1996). Activation of Faset al., 1998).
also results in release of cytochrome c from mitochon-In the current report, we have isolated a protein factor
dria, which can be prevented by inhibitors that blockfrom normal HeLa cellcytosol that mediates cytochrome
caspase-8 activity (Vander Heiden et al., 1997). Basedc release from isolated mitochondria in response to cas-
on these observations, we set up an in vitro assay forpase-8. Mass fingerprinting analysis revealed this pro-
cytochrome c release using mitochondria isolated fromtein to be Bid, a protein known to interact with both
mouse liver and cytosol from normal HeLa cells. AsBcl2 and Bax through its BH3 domain (Wanget al., 1996).
shown in Figure 1, upon addition of recombinant activeBid usually exists in an inactive form in the cytosolic
caspase-8, HeLa cytosol was capable of inducing thefraction of living cells and becomes cleaved and acti-
majority of cytochrome c release from the coincubatedvated by caspase-8. The COOH-terminal part of Bid
mitochondria (lane 4). In contrast, no redistribution ofthen translocates onto mitochondria and is sufficient to
cytochrome c oxidase was detected (Figure 1C and datatrigger cytochrome c release. Elimination of Bid from
not shown). HeLa cytosol or caspase-8 alone had nocell extracts by immunodepletion abolished the cyto-
detectable cytochrome c releasing activity (lanes 2 andchrome c releasing activity. This study establishes Bid
3). Cytochrome c release was inhibited by the cas-as a direct molecular link between the activated cas-
pase-8 inhibitors z-VAD-fmk and cowpox virus proteinpase-8 and mitochondrial death machinery.
CrmA (lanes 5 and 6). Both reagents block Fas and TNF
signaling in vivo (Strasser et al., 1995; Tewari and Dixit,
1995; Krippner et al., 1996; Vander Heiden et al., 1997).Results
Using such an assay, we fractionated HeLa cell cyto-
solic extracts to purify the caspase-8-dependent cyto-Purification of a Cytochrome c Releasing Factor
Upon activation of cell surface death receptor Fas, cas- chrome c releasing factor (CCRF). The complete purifi-
cation of CCRF was achieved through an eight-steppase-8 is recruited into the DISC and becomes activated
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Table 1, eight peptides from the tryptic digestion of
CCRF matched with a known human protein, BH3-con-
taining death agonist, Bid (Wang et al., 1996).
To verify that CCRF is indeed Bid, we generated re-
combinant Bid by bacterial expression and purified the
recombinant Bid to homogeneity. As shown in Figure
3A, Bid displayed caspase-8-dependent cytochrome c
releasing activity in a concentration similar to purified
CCRF. At higher concentrations (20±60 ng/25 ml), Bid
induced cytochrome c release from the coincubated
mitochondria independent of caspase-8 (upper panel).
A point mutation at the conserved BH3 domain of Bid
(G94E), which has previously been shown to abolish its
interaction with both Bax and Bcl2, drastically de-
creased its cytochrome c releasing activity (bottom panel;
Wang et al., 1996).
Since the cytochrome c releasing activity of Bid is
activated by caspase-8, it is likely that Bid is a substrate
of caspase-8. To test that directly, we incubated the
recombinant Bid with caspase-8. Shown in Figure 3B,
caspase-8 cleaved wild-type and G94E Bid into two
fragments of 15 kDa and 11 kDa as measured by SDS-
PAGE (lanes 2 and 6). Protein sequencing analysis of
the 15 kDa cleaved product revealed that the cleavage
is at the aspartic acid 59 after LQTD. Consistently, a
mutation that changed Asp-59 to Ala abolished the
cleavage of Bid by caspase-8 (lane 4). Sucha mutant Bid
lost the caspase-8-dependent cytochrome c releasing
activity but maintained caspase-8-independent activity
when higher concentrations of this protein were used
(Figure 3A, middle panel).
The 15 kDa COOH-terminal cleaved product contains
the BH3 domain, suggesting that it is the functional part
of Bid for cytochrome c release. To test this directly,
Figure 2. Purification of a Caspase-8-Dependent Cytochrome c Re- we generated a recombinant Bid protein truncated at
leasing Factor (CCRF)
the caspase-8 cleavage site Asp-59 and purified it to
(A) Diagram of the purification scheme for CCRF.
homogeneity (Figure 3D). This protein is sufficent to(B) Aliquots of 10 ml fractions from the Mono Q column were incu-
cause cytochrome c release from purified mitochon-bated with aliquots of 3 ml of mouse liver mitochondria (3 mg) in the
dria, and such activity was no longer sensitive to cas-absence or presence of aliquots of 2 ml caspase-8 (20 ng) in a final
volume of 25 ml buffer B. After incubation for 30 min at 308C, the pase-8 and its inhibitors z-VAD-fmk and CrmA (Figure
samples were centrifuged at 12,000 3 g for 5 min at 48C. The re- 3C, lanes 1±5).
sulting supernatants were subjected to 15% SDS-PAGE. After trans- To further confirm that Bid is the caspase-8-depen-
ferring to a nitrocellulose filter, the filter was probed with a mono-
dent cytochrome c releasing factor, an antibody gener-clonal anti-cytochrome c antibody as described in Experimental
ated against recombinant Bid was used to immunode-Procedures. The filter was exposed to X-ray film for 3 s.
plete Bid from HeLa cell S-100 extracts. This antibody(C) Aliquots of 30 ml of the indicated fractions from the Mono Q
column were subjected to 15% SDS-PAGE followed by silver stain- recognizes a single 26 kDa protein in the HeLa cell S-100
ing using a Silver Stain Plus kit from Bio-Rad. extracts by Western blot analysis (data not shown). As
shown in Figure 4, S-100 extracts depleted of Bid lost
the cytochrome c releasing activity (lanes 5 and 6). Pre-
immune serum from the same animal did not deplete
procedure (Figure 2A). The last step of purification, a any cytochrome c releasing activity (lanes 3 and 4).
Mono Q column chromatographic step, is shown in Fig-
ure 2B. CCRF was eluted from the Mono Q column
at z120 mM NaCl (fractions 24±27). The same protein COOH Terminus of Bid Translocates
fractions were subjected to SDS-PAGE followed by sil- onto Mitochondria after
ver staining. A protein band of 26 kDa correlated with Caspase-8 Cleavage
the CCRF activity. To study the mechanism of Bid-induced cytochrome c
release, we translated Bid in vitro in the presence of 35S-
methionine and incubated the translated product withCCRF Is Identical to Bcl2 Interacting Domain
Death Agonist, Bid mitochondria in the presence of caspase-8. After incu-
bation, the mitochondria were pelleted through centrifu-To reveal the identity of CCRF, the 26 kDa protein was
subjected to trypticdigestion, and the resulting peptides gation, and the resulting supernatants and pellets were
analyzed by SDS-PAGE followed by autoradiography.were subjected to mass spectral analysis. As shown in
Cell
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Table 1. Mass Fingerprinting of CCRF and Its Identification as Human Bid
Peptide # Data Submitted MH1 Matched Peptide Sequences Amino Acid Position in Bid
1 1080.54a 1080.62a VASHTPSLLR 159±168
2 1185.67a 1185.76a TMLVLALLLAKK 147±157
3 1209.34b 1209.4b KVASHTPSLLR 158±168
4 1504.63a 1504.71a IEADSESQEDIIR 72±84
5 1549.15b 1548.9b SIPPGLVNGLALQLR 100±114
6 1702.85b 1703.0b DLATALEQLLQAYPR 126±140
7 1818.74b 1819.0b DVFHTTVNFINQNLR 169±183
8 3167.57b 3167.4b ELDALGHELPVLAPQWEGYDELQTDGNR 36±63
Peptides were analyzed by mass fingerprinting in a MALDI-TOF mass spectrometer. The values for m/z of the protonated molecular ions
corresponding to eight tryptic peptides were matched to the sequence of human BH3 interacting domain death agonist (BID) with mass errors
of 0.005±0.016%. These peptides covered 55% of the BID sequence.
a Monoisotopic mass values.
b Average mass values.
As shown in Figure 5, when the cleaved Bid was incu- NH2-terminal part of Bid were found to be associated
with mitochondria (Figures 5A±5C, lanes 4±6). Interest-bated with mitochondria, the COOH-terminal part be-
came associated with the mitochondria (Figures 5A and ingly, the BH3 mutant of Bid (G94E) that showed mark-
edly reduced cytochrome c releasing activityassociated6C, lane 6). In contrast, minimal full-length Bid and no
Figure 3. Recombinant Bid Has Caspase-8-
Dependent Cytochrome c Releasing Activity
Recombinant wild-type, D59A, G94E, and the
truncated Bid (aa 60±195) were generated
and purified as described in Experimental
Procedures.
(A) Aliquots of 3 ml of mitochondria (3 mg)
were incubated with the indicated amounts of
recombinant wild-type Bid (top panel), D59A
Bid (middle panel), or G94E Bid (bottom
panel) in the absence or presence of aliquots
of 2 ml caspase-8 (20 ng) as indicated. After
30 min incubation at 308C, the samples were
centrifuged at 12,000 3 g for 5 min at 48C.
The resulting supernatants were subjected to
15% SDS-PAGE and transferred to a nitrocel-
lulose filter. The filter was probed with a
monoclonal anti-cytochrome c antibody as
described in Experimental Procedures. The
filters were exposed to X-ray film for 3 s.
(B) Aliquots of 10 mg of recombinant wild-
type Bid (lanes 1 and 2), D59A Bid (lanes 3
and 4), or G94E Bid (lanes 5 and 6) were incu-
bated in the presence or absence of aliquots
of 2 ml caspase-8 as indicated for 30 min
at 308C. After incubation, the samples were
subjected to 15% SDS-PAGE, and the gel
was subsequently stained by Coomassie bril-
liant blue.
(C) Aliquots of 3 ml of mitochondria were incu-
bated with mitochondria resuspension buffer
alone (lane 1) or 2 ng of truncated Bid in the
absence (lane 2) or presence (lanes 3±5) of
aliquots of 2 ml of caspase-8 (20 ng). In lanes
4 and 5, aliquot of 0.3 mg of CrmA (lane 4) or
zVAD-fmk at a final concentration of 20 mM
was preincubated with caspase-8 for 15 min
prior to the addition of mitochondria and Bid.
After 60 min incubation at 308C, the samples
were centrifuged at 12,000 3 g for 5 min at
48C, and the resulting supernatants were ana-
lyzed by Western blot using an anti-cyto-
chrome c antibody as in (A).
(D) An aliquot of 0.5 mg of truncated Bid (aa
60±195) was subjected to 15% SDS-PAGE,
and the gel was subsequently stained by
Coomassie brilliant blue.
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Figure 4. Bid Is Required for Caspase-8-Induced Cytochrome c Re-
lease from Mitochondria
An aliquot of 500 ml of Protein A agarose (Santa Cruz) was incubated
with an aliquot of 500 ml of preimmune or immune serum against
human recombinant Bid at 48C overnight. The antibody/Protein A
agarose beads were collected by centrifugation and washed five
times with buffer A. The beads were resuspended in 1 ml buffer A,
Figure 5. The COOH-Terminal Part of Bid Translocates onto theand aliquots (50 ml) of these beads were then incubated with 1 ml
Mitochondria after Cleavage by Caspase-8HeLa cell S-100 overnight at 48C. The beads were subsequently
pelleted by centrifugation, and the supernatants were used as ex- Recombinant wild-type, D59A, and G94E Bid were in vitro±
tracts immunodepleted of Bid. The cytochrome c present in these translated in the presence of 35S-methionine and affinity-purified as
extracts was also immunodepleted as in Liu et al., 1996b. described in Experimental Procedures.
(A) Duplicate samples of HeLa S-100 (50 mg) (lanes 1 and 2), or HeLa Aliquots of 2 ml of in vitro±translated, 35S-methionine-labeled, and
S-100 immunodepleted with the preimmune serum (50 mg) (lanes 3 affinity-purified wild-type Bid (A), D59A Bid (B), or G95E Bid (C) were
and 4), or HeLa S-100 immunodepleted with an antiserum raised incubated with (lanes 2, 4, and 6) or without aliquots of 2 ml cas-
against recombinant Bid (50 mg) (lanes 5 and 6) were subjected to pase-8 (lanes 1, 3, and 5) in the presence of aliquots of 6 ml mitochon-
15% SDS-PAGE and transferred to a nitrocellulose filter. The filter dria. In lanes 1 and 2, mitochondria were omitted from the mixtures.
was probed with the anti-Bid antibody as described in Experimental After 30 min incubation at 308C, the samples were centrifuged at
Procedures. The filter was exposed to X-ray film for 3 s. 12,000 3 g for 5 min at 48C, and the resulting supernatants (lanes
(B) Aliquots of 50 mg of HeLa S-100 (lanes 1 and 2), or HeLa S-100
3 and 4) and pellets (lanes 5 and 6) were subjected to 15% SDS-immunodepleted with the preimmune serum (lanes 3 and 4), or HeLa
PAGE and transferred to a nitrocellulose filter that was subsequentlyS-100 immunodepleted with an antiserum raised against recombi-
exposed to X-ray film for 16 hr at room temperature.nant Bid (lanes 5 and 6) were incubated with 3 ml of mitochondria
(3 mg) in the absence (lanes 1, 3, and 5) or presence (lanes 2, 4, and
6) of 2 ml of caspase-8 (20 ng). After 30 min incubation at 308C, the signals (Kluck et al., 1997; Yang et al., 1997). To test the
samples were centrifuged at 12,000 3 g for 5 min at 48C. The re- role of Bcl2 during cytochrome c release induced by
sulting supernatants were subjected to 15% SDS-PAGE and trans-
Bid, we isolated mitochondria from human leukemia cellferred to a nitrocellulose filter. The filter was probed with a mono-
line HL60 cellsstably transfected with human Bcl2 cDNAclonal anti-cytochrome c antibody, and the filter was exposed to
X-ray film for 3 s. or the neo vector control. The overexpression of Bcl2
protein on the mitochondria isolated from Bcl2 cells
was verified by Western blot analysis using an antibody
with the mitochondria to the same extent as the wild against Bcl2 (Figure 6A). The same amount of mitochon-
type (Figure 5C, lane 6). dria from these two cell lines was incubated with in-
creasing amounts of Bid in the presence of caspase-8.
Mitochondria from Bcl2 Overexpressed Cells As shown in Figure 6B, cytochrome c was completely
Show Decreased Response to Bid released from mitochondria of neo cells in the presence
Overexpression of Bcl2 blocks cytochrome c release of 0.2 ng of Bid (lane 2). In contrast, the same concentra-
tion of Bid did not induce any cytochrome c releasefrom mitochondria in response to a variety of apoptotic
Cell
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Bid Is Cleaved during Fas-Induced Apoptosis
To demonstrate that Bid is indeed cleaved in vivo during
Fas activation, we treated Jurkat cells with an agonistic
antibody against Fas at different time points and ana-
lyzed Bid, caspase-3, and its substrate DFF45 by West-
ern blot analysis. As shown in Figure 7A, Bid exists as
an z26 kDa protein in growing cells (lane 1). After a 1
hr treatment with anti-Fas antibody, a smaller cleaved
fragment of Bid appeared (Figure 7A, lane 2, lower
panel). This fragment was further cleaved into a slightly
smaller fragment after a 4 hr treatment (lanes 4 and 5).
This is likely due to the activation of a caspase(s) that
cleaves Bid after Asp-74 at the IEAD site, a putative
cleavage site for the downstream caspases such as
caspase-6. The NH2-terminal cleaved fragment was not
recognized by this anti-Bid antibody. The amount of the
26 kDa Bid was significantly decreased after a 2 hr
treatment and became nondetectable after a 4 hr treat-
ment (lanes 3±5). The cleavage of Bid was completely
prevented when a caspase inhibitor, z-VAD-fmk, was
added together with the anti-Fas antibody (lane 6). The
cleavage of Bid during Fas-induced apoptosis occurred
earlier than the cleavage of caspase-3 and its substrate
DFF45 (Figures 7B and 7C). The cleaved caspase-3 and
DFF45 started after a 2 hr treatment with anti-Fas anti-
body, and their precursors disappeared after a 6 hr
treatment.
Discussion
Bid Bridges the Activation of Cell Surface DeathFigure 6. Bcl2 Overexpression Antagonized Bid-Induced Cyto-
Receptors and Mitochondriachrome c Release
Activation of Fas on the cell membrane by Fas ligand orMitochondria-enriched pellets from human leukemia HL-60/neo and
agonist antibody results in the activation of caspase-8,HL-60/Bcl2 cells were prepared as described in Yang et al., 1997.
(A) Mitochondria-enriched pellets from HL-60/neo and HL-60/Bcl2 the apical caspase in this pathway (Boldin et al., 1996;
were subjected to 15% SDS-PAGE and transferred to a nitrocellu- Muzio et al., 1997). In the presence of high concentra-
lose filter. The filter was probed with a monoclonal anti-Bcl2 anti- tions of caspase-8, thedownstream caspases were acti-
body as described in Experimental Procedures. The filter was ex- vated independent of mitochondria and the activation
posed to film for 30 s.
was insensitive to Bcl-xL (Kuwana et al., 1998; Scaffidi(B) Aliquots of 3 ml mitochondria-enriched pellets from HL-60/neo
et al., 1998). When mitochondria were present, however,cells (lanes 1±4) or from HL-60/Bcl2 cells (lanes 5±8) were incubated
with aliquots of 2 ml caspase-8 plus the indicated amount of recom- the effect of low concentrationsof caspase-8 was ampli-
binant Bid for 30 min at 308C. After incubation, the samples were fied through cytochrome c±dependent caspase activa-
centrifuged at 12,000 3 g for 5 min at 48C. The resulting supernatants tion, an event blocked by Bcl-xL (Kuwana et al., 1998;
(top panel) and pellets (bottom panel) were subjected to 15% SDS- Medema et al., 1998; Scaffidi et al., 1998; Srinivasan
PAGE and transferred to a nitrocellulose filter. The filter was probed
et al., 1998). Cytochrome c release from mitochondriawith a monoclonal anti-cytochrome c antibody, and the filter was
induced by Fas activation can also be blocked by cas-exposed to film for 3 s.
(C) Aliquots of 2 ml of in vitro±translated, 35S-methionine-labeled, pase-8 inhibitors such as z-VAD-fmk or CrmA (Krippner
and affinity-purified Bid were incubated without (lanes 1, 3, 5, and et al., 1996; Vander Heiden et al., 1997; Scaffidi et al.,
7) or with (lanes 2, 4, 6, and 8) aliquots of 2 ml caspase-8 in the 1998). Caspase-8 therefore functions upstream of mito-
presence of aliquots of 6 ml mitochondria-enriched pellets from HL- chondria in the Fas pathway. Activated caspase-8 has
60/neo (lanes 1±4) or HL-60/Bcl-2 (lanes 5±8).After 30 minincubation
been proposed to relay the cell membrane death signalat 308C, the samples were centrifuged at 12,000 3 g for 5 min at
to mitochondria through a cytosolic mediator (Krippner48C. The resulting supernatants (lanes 1, 2, 5, and 6) and pellets
(lanes 3, 4, 7, and 8) were subjected to 15% SDS-PAGE and trans- et al., 1996). We have now identified and purified such
ferred to a nitrocellulose filter that was subsequently exposed to a mediator that directly triggers cytochrome c release
X-ray film for 16 hr at room temperature. in purified mitochondria after cleavage by caspase-8.
This protein is Bid, a member of BH3 domain±containing
proteins (Wang et al., 1996).from mitochondria of Bcl2 cells (lane 5). However, the
inhibitory effect of Bcl2 was overcome by a 10-fold Bid contains a single BH3 domain, a domain also
shared by several other proapoptosis members of thishigher concentration of Bid (lane 8). Consistent with
the data shown in Figure 5, COOH-terminal part of the family such as Bad and Bax (Oltvai et al., 1993; Zha
et al., 1996). Interestingly, Bid lacks other homologouscleaved Bid associated with mitochondria from both neo
and Bcl2 cells (Figure 6C, lanes 4 and 8). domains found in the Bcl2 family of proteins such as
Bid Mediates Cytochrome c Release
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Figure 7. Cleavage of Bid In Vivo during Fas
Activaion
Human lymphoblastoid T-cell Jurkat cells
(3 3 106) in RPMI 1640 medium supplemented
with 10% (v/v) fetal bovine serum, 100 U/ml
penicillin, and 100 mg/ml streptomycin sulfate
were treated with 500 ng/ml monoclonal anti-
human Fas antibody (clone CH11, Upstate
Biotech.) for the indicated time points. In lane
6, z-VAD-fmk was added to a final concentra-
tion of 20 mM together with the anti-Fas anti-
body. The cells were collected by centrifuga-
tion at 1,000 3 g for 10 min at 48C. After
washing twice with ice-cold PBS, the cell pel-
lets were lysed in 300 ml of 13 SDS-PAGE
loading buffer. Aliquots of 30 mg of Jurkat
whole cell lysate were loaded to three 15%
SDS-PAGE gels and transferred to nitrocellu-
lose filters.
(A) The first filter was probed with a rabbit
polyclonal anti-Bid antibody (1:2000 dilution)
as described in Experimental Procedures.
The filter was exposed to X-ray film for 3 s to
visualize the full-length Bid (upper panel) and
further exposed to another film for 60 s to
visualize the cleaved Bid (lower panel).
(B) The second filter was probed with a
mouse monoclonal antibody against cas-
pase-3 (Signal Transduction Lab.), and the
antigen-antibody complexes were detected by an ECL method. The filter was exposed to X-ray film for 5 min.
(C) The third filter was probed with a rabbit polyclonal antibody against DFF-45 as described in Liu et al., 1997, and the antigen-antibody
complexes were detected by an ECL method. The filter was exposed to X-ray film for 3 s.
BH1, BH2, BH4, and COOH-terminal membrane anchor- than Bax. Bax only releases up to 20% of the total mito-
chondrial cytochrome c even at a high concentrationing domain. It is able to interact with both pro- and
(200 nM) (Jurgensmeier et al., 1998). Bid, on the otherantiapoptosis members of this family (Wang et al., 1996).
hand, was able to release close to 100% of mitochon-Overexpression of Bid potentiates apoptosis induced
drial cytochrome c at a 500-fold lower concentrationby serum withdrawal (Wang et al., 1996). Such an obser-
(z0.2±2 nM) (Figure 3). Further, the minimum Bax thatvation is consistent with its role as a mediator of apo-
was needed to trigger cytochrome c release is aboutptotic signals. Recently, a BH3-containing proapoptosis
0.1 mM. In contrast, 0.2 nM of Bid caused completeprotein, EGL-1, has been isolated from C. elegans (Con-
cytochrome c release (Figure 6B).radt and Horvitz, 1998). EGL-1 has been shown to func-
Bid initiates the release of cytochrome c apparentlytion upstream of CED-9, a C. elegans homolog of Bcl2,
without evoking gross mitochondrial swelling and per-to trigger apoptosis in this organism. Like Bid, EGL-1
meability transition, two events that have been pro-contains a single BH3 domain that mediates its interac-
posed to cause cytochrome c release (Budihardjo andtion with CED-9 but lacks other recognizable homology
Wang, data not shown; Susin et al., 1997; Vander Heidenwith the Bcl2 family of proteins. EGL-1 and Bid may
et al., 1997; Pastorino et al., 1998). Such a finding indi-therefore represent upstream apoptotic signaling mole-
cated that loss of mitochondrial membrane potential iscules that relay the signal to CED-9 and Bcl2, respec-
not the cause for Bid-mediated cytochrome c release.tively.
The BH3 domain of Bid is important for its function,
and such a domain dimerizes with other Bcl2 family
How Does Bid Cause Cytochrome c Release? members (Wang et al., 1996). Thus, it is possible that
Bid exists in the cytosolic fraction of living cells as an Bid will form a complex with a proapoptotic member of
inactive precursor that becomes activated upon cleav- the family like Bax to trigger cytochrome release from
age by caspase-8. The cleavage occurs at aspartic acid mitochondria. Alternatively, Bid may inactivate an anti-
59 after the LQTD site, a site conserved between human apoptotic member of the Bcl2 family that plays an active
and mouse Bid (Wang et al., 1996). After cleavage, the role in preventing cytochrome c release. Interestingly,
COOH fragment of Bid translocates onto mitochondria, a BH3 mutant (G94E) of Bid that is defective in cyto-
an event that is independent of its BH3 domain (Figure chrome c release (Figure 3A) and is unable to interact
5). The activated Bid by itself is sufficient to induce with Bcl2 or Bax (Wang et al., 1996) associates with
complete release of cytochrome c from mitochondria mitochondria to the same extent as wild-type Bid (Figure
(Figure 4C). Recently, Bax, another proapoptotic mem- 5C). This finding indicates that Bid may interact with a
ber of the Bcl2 family of proteins has been shown to yet unidentified target on the outer membrane of mito-
induce cytochrome c release both in vivo and in vitro chondria. However, this protein±protein (or protein±lipid)
(Jurgensmeier et al., 1998; Rosse et al., 1998). However, interaction is not sufficient to trigger cytochrome c re-
lease, an event that also requires the interaction withBid is a much more potentcytochrome c releasing factor
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into bacteria BL21 (DE3) cells (Novagen), and the recombinant cas-another protein through its BH3 domain. Although the
pase was prepared as in Liu et al., 1997, and stored in multiplemolecular mechnism of cytochrome c release is still
aliquots at 2808C. A 3 ml aliquot of mouse liver mitochondria wasobscure, the reconstitution of this reaction with the re-
incubated with the indicated protein fraction in the presence or
combinant, constitutively active Bid (aa 60±195) will absence of a 2 ml aliquot of recombinant caspase-8 in a final volume
allow us to further study this process in detail. of 25 ml buffer B (220 mM mannitol, 68 mM sucrose, 20 mM HEPES-
KOH [pH 7.5], 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 1
mM sodium EGTA, 1 mM dithiothreitol, and 0.1 mM PMSF) at 308Does Bid Mediate Cytochrome c Release
for 30 min. At the end of incubation, the reaction mixture was centri-in Response to Stimuli Other
fuged at 12,000 3 g for 5 min at 48C to pellet the mitochondria.
than Caspase-8? Eight microliters of 43 SDS sample buffer was added to the resulting
It will be interesting to see whether other death signals supernatants. The mitochondria pellets were resuspended in equal
such as excessive DNA damage and growth factor dep- volume (33 ml) of 13 SDS sample buffer. The samples were boiled
for 3 min and subjected to 15% SDS-PAGE. The gel was transferredrivation also exert their apoptotic effects on mitochon-
to a nitrocellulose filter and probed with a mouse monoclonal anti-dria through Bid. Overexpression of Bid potentiates cell
cytochrome c antibody (from Dr. R. Jemmerson) or a mouse mono-death induced by IL-3 withdrawal, indicating the involve-
clonal anti-cytochrome c-oxidase antibody (Molecular Probes).
ment of Bid in this pathway (Wang et al., 1996). It is Western blot analysis for cytochrome c was performed as described
possible that Bid could be activated by other forms of previously (Liu et al., 1996b). Antigen/antibody complexes were de-
posttranslational modification such as phosphorylation. tected using a horseradish peroxidase conjugated goat anti-mouse
(for both cytochrome c and cytochrome c oxidase) immunoglobulinAlternatively, Bid may be regulated by proteins such
G using enhanced chemiluminescence Western blotting detectionas 14±3±3, which regulate the activity of another BH3-
reagents (Amersham).containing protein, Bad (Zha et al., 1996). Moreover, Bid
might be activated by caspases other than caspase-8
Purification of Caspase-8-Dependent Cytochrome cto form an amplification loop for caspase activation.
Releasing Factor from HeLa S-100
Conversely, there could be other BH3-containing pro- All purification steps were carried out at 48C. All chromatography
apoptotic proteins such as Bad and Bax that migrate steps except the Q-Sepharose column (Pharmacia) were carried
from cytosol to mitochondria upon apoptotic stimuli and out using an automated fast protein liquid chromatography (FPLC)
station (Pharmacia).interact with the same mitochondrial target as Bid
Six hundred milliliters (3 g of protein) of HeLa S-100 from 100 l of(Wolter et al., 1997; Zha et al., 1996). Now with the identi-
suspension-cultured HeLa cells were prepared as described in Liufication of Bid as a cytochrome c releasing factor, all
et al., 1996b, and applied to a Q-Sepharose column (100 ml bed
these possibilities become testable hypotheses. volume) equilibrated with buffer A (20 mM HEPES-KOH [pH 7.5], 10
mM KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA,
Experimental Procedures 1 mM dithiothreitol, and 0.1 mM PMSF). The column was washed
with three column volumes of buffer A and eluted with four column
We obtained dATP and other nucleotides from Pharmacia, radioac- volumes of buffer A containing 0.1 M NaCl and four column volumes
tive materials from Amersham, and molecular weight standards for of buffer A containing 0.2 M NaCl. The protein peak from the 0.2 M
SDS-PAGE and gel filtration chromatography from Bio-Rad. Protein NaCl elution (250 ml, 314 mg protein) was heated at 658C for 15 min
concentrations were determined by the Bradford method, and gen- and centrifuged at 20,000 3 g for 15 min to precipitate denatured
eral molecular biology methods were used as described in Sam- proteins. Ammonium sulfate (30%) was added directly to the super-
brook et al., 1989. Mouse monoclonal anti-cytochrome c antibody natant (240 ml, 36 mg protein). After stirring at 48C for 1 hr, the
(clone 7H8.2C11) was a generous gift from Dr. Ronald Jemmerson mixture was centrifuged at 20,000 3 g for 15 min. Ammonium sulfate
(University of Minnesota). was added to the supernatant to a final concentration of 80% and
stirred at 48C for 1 hr. The mixture was then centrifuged again at
Preparation of Mitochondria 20,000 3 g for 15 min at 48C. The resulting pellet (13 mg protein)
Mouse liver mitochondria were isolated as described by Ellerby et was resuspended in 8 ml buffer A, loaded onto a Superdex-200 Hi-
al., 1996. In brief, the mouse livers were removed after sacrifice and Load (26/60) gel filtration column (300 ml) equilibrated with buffer
dounce homogenized in ice-cold mitochondria isolation buffer (MIB) A containing 0.1 M NaCl, and eluted with the same buffer. Fractions
containing 250 mM mannitol, 0.5 mM EGTA, 5 mM HEPES, and of 4 ml were collected (two runs) and assayed for CCRF activity.
0.1% (w/v) BSA (pH 7.2) supplemented with the protease inhibitors The active fractions from the gel filtration column (48 ml, 4 mg
of leupeptin (1 mg/ml), pepstatin A (1 mg/ml), antipain (50 mg/ml), protein) were pooled and loaded onto a 1 ml hydroxylapatite column
and PMSF (0.1 mM). Unbroken cells and nuclei were pelleted by (Bio-Rad) equilibrated with buffer A. The column was eluted with a
centrifugation at 600 3 g for 5 min at 48C. The supernatants were linear gradient of 10 ml buffer A to 50 mM KPO4 (pH 7.5) followed
further centrifuged at 10,000 3 g for 10 min at 48C to pellet the by 15 ml buffer A containing 50 mM KPO4 (pH 7.5). Fractions of 1 ml
mitochondria. The mitochondria pellet was resuspended in 4 ml MIB were collectedand assayed for CCRF activity. The active fractions (6
and loaded onto a continuous Percoll gradient consisted of 30% ml, 1 mg protein) were pooled, and ammonium sulfate was added
(v/v) Percoll (Sigma), 225 mM mannitol, 25 mM HEPES, 0.5 mM directly to these fractions to a final concentration of 1 M. The frac-
EGTA, and 0.1% (w/v) BSA (pH 7.2). The suspension/gradient was tions were then loaded onto a 1 ml Phenyl-superose column (Phar-
centrifuged at 40,000 3 g for 1 hr. The mitochondria were removed macia) equilibrated with buffer A containing 1 M ammonium sulfate
from the brownish band at 1.10 g/ml with a transfer pipette. The andeluted with 15 ml buffer A containing 400 mM ammonium sulfate.
mitochondrial pellets were washed with MIB by centrifuging for 10 Fractions of 1 ml were collected and assayed for CCRF activity. The
min at 6300 3 g at 48C. The mitochondria were then resuspended active fractions (6 ml, 286 mg protein) were loaded onto a Superdex-
gently in mitochondria resuspension buffer containing 400 mM man- 200 (10/30) gel filtration column equilibrated with buffer A containing
nitol, 10 mM KH2PO4, and 50 mM Tris-HCl (pH 7.2) with 5 mg/ml 0.1 M NaCl and eluted with the same buffer (12 runs). Fractions of
BSA and stored on ice for up to 4 hr. 1 ml were collected and assayed for CCRF activity. Pooled active
Mitochondria-enriched pellets from HL-60/neo and HL-60/bcl2 fractions from the gel filtration column (25 ml, 155 mg protein) were
cell lines were prepared as described in Yang et al., 1997. loaded directly onto a Mono Q 5/5 column (Pharmacia) equilibrated
with buffer A containing 60 mM NaCl. The column was eluted with
a 50 ml linear gradient from 60 mM NaCl to 250 mM NaCl, both inIn Vitro Assay for Cytochrome c Release
The full-length caspase-8 in pET28 (Novagen) was described in buffer A. Fractions of 1 ml were collected and assayed for CCRF
activity.Srinivasula et al., 1996. The expression plasmid was transformed
Bid Mediates Cytochrome c Release
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Protein Identification of CCRF by Peptide Mass Fingerprinting (Novagen). The resulting fusion proteins with six histidines were
A 10 pmol aliquot of CCRF purified through the Mono Q column translated in a TNT T7 transcription/translation kit (Promega) in the
step was subjected to SDS polyacrylamide gel electrophoresis. After presence of 35S-methionine according to the manufacturer's instruc-
staining with Coomassie blue R-250, the 26 kDa band was excised tion. The translated proteins were passed through 1 ml nickel affinity
from the gel and digested with trypsin as described (Jensen et al., columns (Qiagen) equilibrated with buffer A. After washing the col-
1996). A 1 ml aliquot of the total digest (total volume 30 ml) was umns with 10 ml buffer A containing 1 M NaCl, the columns were
used for peptide mass fingerprinting (Williams and Stone, 1995). reequilibrated with buffer A, and the translated proteins were eluted
The masses of the tryptic peptides were measured with a Voyager with buffer A containing 250 mM imidazole (Sigma).
DE time-of-flight (TOF) mass spectrometer (Perseptive Biosystems,
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